ESR2 and ovarian carcinoma: They found that PES1 enhanced the stability of ERα while targeting ERβ for proteasomal degradation, thereby increasing the protein levels of ERα and decreasing those of ERβ, which contributed to the development and progression of breast and ovarian cancers.